Early-life nutrition review: Integrated brain-gut-sleep model redefines product strategy
A new review challenges siloed approaches to early-life nutrition, advocating for integrated product development focusing on the brain-gut-sleep triad during the first 1,000 days.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Santiago, Chile — 04 May 2026
A recent review published in Nutrients, led by SmartyPants Vitamins scientists, posits that early-life nutrition's influence on development significantly transcends current prenatal and infant supplement strategies. The paper introduces a 'brain-gut-sleep triad' concept, asserting that these systems develop interdependently during the first 1,000 days, with nutrition acting as a critical modifiable factor.
Devyani Chaturvedi, senior nutrition scientist at SmartyPants Vitamins and lead author, highlighted the significant gap between the actual integration of early development and prevailing siloed research. This integrated perspective directly challenges the industry's historical emphasis on single nutrients for specific outcomes. Instead, the review emphasizes that a complementary array of nutrients – including omega-3 fatty acids, choline, folate, iodine, vitamin B12, iron, vitamin D, and probiotics – concurrently influences multiple developmental pathways. This necessitates a shift from identifying a single 'hero' nutrient to understanding synergistic nutrient combinations.
Maternal nutrition is central to this framework, with the review underscoring its direct impact on fetal brain development, gut microbial maturation, and sleep regulation. The authors advocate for formulation strategies that recognise these complex interactions, moving beyond isolated outcomes to comprehensive support for the entire 'triad'. This implies a re-evaluation of nutrient forms, bioavailability, and dosing in real-world scenarios, which could affect manufacturing MOQs and lead times for ingredient procurement.
Despite the comprehensive nature of the review, the authors acknowledge existing evidence gaps, particularly regarding integrated, longitudinal studies linking nutrition to long-term outcomes across these interconnected systems. This highlights a need for more robust research to inform future product development and regulatory guidance. The review also implies a need for standardised, evidence-based nutrient recommendations for early childhood that reflect this integrated understanding.
What this means for Chile
Chilean supplement manufacturers and brand owners must adapt to this systems-level nutrition paradigm. Reformulating products to address the brain-gut-sleep triad simultaneously will require substantial R&D investment, potentially increasing ingredient costs by 10-15% due to the inclusion of a broader nutrient spectrum. Compliance with ISP (Instituto de Salud Pública) regulations for claims substantiation will demand new clinical data supporting multi-faceted efficacy, particularly for products targeting the first 1,000 days. Early movers who embrace this integrated view can gain a competitive advantage in the premium segment, differentiating from brands with single-nutrient offerings and addressing a more sophisticated consumer understanding of early development. Inventory management will also become more complex, necessitating closer collaboration with ingredient suppliers to manage varied lead times.
Many leading brands in this category are manufactured in partnership with Supplement Factory.